|
AU3738700A
|
|
Stabilized bicyclo(3.3.1)nonenes and methods of use
|
|
WO0054760A2
|
|
Bicyclo (3.3.1) nonenes useful for the treatment of diabetes and hypertriglyceridemia
|
|
AU2979000A
|
|
Enteric formulations of proanthocyanidin polymer dietary supplements and methodsfor preparing same
|
|
AU1924099A
|
|
Piperazine derivatives useful as hypoglycemic agents
|
|
AU8759298A
|
|
Use of nordihydroguaiaretic acid to lower serum triglycerides, blood pressure and to treat syndrome
|
|
KR20000049206A
|
|
Enteric Formulation of Proanthocyanidin Polymer Anti-diarrheal Compositions
|
|
AU2124197A
|
|
Aniline derivatives having antihyperglycemic activity
|
|
US5741926A
|
|
Aniline derivatives having antihyperglycemic activity
|
|
US5837255A
|
|
Method of reducing blood glucose by administering Harunganin or Vismin
|
|
US5827898A
|
|
Use of bisphenolic compounds to treat type II diabetes
|
|
CA2230856A1
|
|
Methods and compositions for treating fungal infections in mammals
|
|
US5691386A
|
|
Triterpenoid compound for the treatment of diabetes
|
|
AU3731895A
|
|
Cryptolepine analogs with hypoglycemic activity
|
|
US5674900A
|
|
Terpenoid-type quinones for treatment of diabetes
|
|
US5681958A
|
|
Cryptolepine analogs with hypoglycemic activity
|
|
US5747527A
|
|
Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
|
|
AU1989195A
|
|
Preparation of symmetrical and unsymmetrical dithiin compounds
|
|
US5580897A
|
|
1,2-dithiins having antifungal activity
|
|
US5648354A
|
|
1,2-dithiins having antifungal activity
|
|
US5917052A
|
|
Hypoglycemic agent from cryptolepis
|
